Emerging biopharmaceutical company selects Clinical Force for its CTMS. The company is commercially focused and has a number of products in clinical trials. The company operates an outsourcing model and have an established network of research and development partners who will use the CTMS. The key functional drivers are consolidated reporting and Investigator payments. The monthly subscription model means that it will pay for itself in the first study. The system will be implemented within 2 weeks.